HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Anaplasmosis — Clinical Guidelines

Overview

Anaplasmosis is a tick-borne disease caused by various species of the Anaplasma bacteria, affecting both animals and humans. In humans, it primarily manifests as human granulocytic anaplasmosis (HGA) caused by Anaplasma phagocytophilum 2.

Diagnosis

Clinical Presentation: Fever, headache, myalgia, leukopenia, anemia, and thrombocytopenia 2 3.

Laboratory Tests: Complete blood count (CBC) showing leukopenia, anemia, and thrombocytopenia; blood smear examination for morulae in neutrophils 2 3.

Serological Testing: Indirect fluorescent antibody (IFA) tests for Anaplasma species 2.

Molecular Diagnostics: PCR analysis targeting Anaplasma-specific genes 3.

Management

First-Line Treatment: Doxycycline is the recommended first-line treatment for HGA 2.

Duration: Typically 10-14 days for adults and children 2.

Adjunctive Care: Supportive care including hydration, fever management, and monitoring for complications such as SIRS/MODS 2.

Special Populations

Elderly: Higher incidence noted in older adults (50-59 years) 2.

Comorbidities: No specific recommendations provided in the abstracts regarding comorbidities, but close monitoring is advised given potential for severe complications 2.

Key Recommendations

Diagnose HGA using clinical symptoms, CBC, blood smear for morulae, and PCR testing (Evidence: Moderate 2 3).

Initiate doxycycline therapy as first-line treatment for confirmed or suspected HGA (Evidence: Moderate 2).

Monitor elderly patients closely due to higher incidence in older adults (Evidence: Moderate 2).

References

1 Köseoğlu AE, Can H, Güvendi M, Erkunt Alak S, Değirmenci Döşkaya A, Karakavuk M et al.. Molecular characterization of Anaplasma ovis Msp4 protein in strains isolated from ticks in Turkey: A multi-epitope synthetic vaccine antigen design against Anaplasma ovis using immunoinformatic tools. Biologicals : journal of the International Association of Biological Standardization 2024. link 2 Li H, Zhou Y, Wang W, Guo D, Huang S, Jie S. The clinical characteristics and outcomes of patients with human granulocytic anaplasmosis in China. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2011. link 3 Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?. JAMA 1994. link 4 James MA, Coronado A, Melendez RD, Ristic M. Antigen beads: a novel approach for the delivery of a soluble Anaplasma immunogen. American journal of veterinary research 1984. link

Anaplasmosis